UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines

Annals of oncology, 2008-06, Vol.19 (6), p.1053-1059

2008

Volltextzugriff (PDF)

A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop

Oncogenesis (New York, NY), 2013-03, Vol.2 (3), p.e39-e39

2013

Volltextzugriff (PDF)

PTTG1 Levels Are Predictive of Saracatinib Sensitivity in Ovarian Cancer Cell Lines

Clinical and translational science, 2016-12, Vol.9 (6), p.293-301

2016

Volltextzugriff (PDF)

Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas

British journal of cancer, 2002-05, Vol.86 (9), p.1449-1456

2002

Volltextzugriff (PDF)

Expression of Her-2/neu in Human Lung Cancer Cell Lines by Immunohistochemistry and Fluorescence in Situ Hybridization and its Relationship to in Vitro Cytotoxicity by Trastuzumab and Chemotherapeutic Agents

Clinical cancer research, 2001-10, Vol.7 (10), p.3239-3250

2001

Volltextzugriff (PDF)

Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines

Cancer research (Chicago, Ill.), 2006-01, Vol.66 (2), p.944-950

2006

Volltextzugriff (PDF)

The Effects of Cetuximab Alone and in Combination With Radiation and/or Chemotherapy in Lung Cancer

Clinical cancer research, 2005-01, Vol.11 (2), p.795-805

2005

Volltextzugriff (PDF)

Effects of recombinant neutral endopeptidase (EC 3.4.24.11) on the growth of lung cancer cell lines in vitro and in vivo

Clinical cancer research, 1998-11, Vol.4 (11), p.2849-2858

1998

Volltextzugriff (PDF)

288 POSTER The selective Aurora B kinase inhibitor AZD1152 inhibits in vitro growth in small cell lung cancer (SCLC) cell lines

European journal of cancer supplements, 2008, Vol.6 (12), p.93-93

2008

Volltextzugriff (PDF)

"Total Synthesis" Supramolecular Style: Design and Hydrogen-Bond-Directed Assembly of Ternary Supermolecules

Angewandte Chemie (International ed.), 2001-09, Vol.40 (17), p.3240-3242

2001

Volltextzugriff (PDF)

A High-Yielding Supramolecular Reaction

Journal of the American Chemical Society, 2002-12, Vol.124 (48), p.14425-14432

2002

Volltextzugriff (PDF)

436 COMBINING THE SRC INHIBITOR AZD0530 WITH IONIZING RADIATION YIELDS ADDITIVE EFFECTS WITHOUT MODULATION OF PHOSPHOSITES ON SRC, EPIDERMAL GROWTH FACTOR RECEPTOR, OR MITOGEN-ACTIVATED PROTEIN KINASE

Journal of investigative medicine, 2006-01, Vol.54 (1), p.S154-S155

2006

Volltextzugriff (PDF)

Altered HOX and WNT7A Expression in Human Lung Cancer

Proceedings of the National Academy of Sciences - PNAS, 2000-11, Vol.97 (23), p.12776-12781

2000

Volltextzugriff (PDF)

Epidermal growth factor receptor family in lung cancer and premalignancy

Seminars in oncology, 2002-02, Vol.29 (1), p.3-14

2002

Volltextzugriff (PDF)

Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines

Cancer research (Chicago, Ill.), 1999-12, Vol.59 (24), p.6178-6184

1999

Volltextzugriff (PDF)

Targeted therapies for non–small-cell lung cancer: biology, rationale, and preclinical results from a radiation oncology perspective

International journal of radiation oncology, biology, physics, 2004-01, Vol.59 (2), p.S27-S38

2004

Volltextzugriff (PDF)

Peritoneal catheters and exit-site practices: toward optimum peritoneal access

Peritoneal dialysis international, 1993, Vol.13 (1), p.29-39

1993

Volltextzugriff (PDF)

Do Polymorphic Compounds Make Good Cocrystallizing Agents? A Structural Case Study that Demonstrates the Importance of Synthon Flexibility

Crystal growth & design, 2003-03, Vol.3 (2), p.159-165

2003

Volltextzugriff (PDF)

Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma

The Journal of immunology (1950), 1989-12, Vol.143 (12), p.4282-4286

1989

Volltextzugriff (PDF)

Heteromeric intermolecular interactions as synthetic tools for the formation of binary co-crystals

CrystEngComm, 2004-01, Vol.6 (5), p.19-24

2004

Volltextzugriff (PDF)

Bradykinin Antagonist Dimer, CU201, Inhibits the Growth of Human Lung Cancer Cell Lines by a "Biased Agonist" Mechanism

Proceedings of the National Academy of Sciences - PNAS, 2002-04, Vol.99 (7), p.4608-4613

2002

Volltextzugriff (PDF)

Exisulind in Combination with Docetaxel Inhibits Growth and Metastasis of Human Lung Cancer and Prolongs Survival in Athymic Nude Rats with Orthotopic Lung Tumors

Clinical cancer research, 2002-03, Vol.8 (3), p.904-912

2002

Volltextzugriff (PDF)

The Lawrence D. Dorr Surgical Techniques & Technologies Award: Differences in Postoperative Outcomes Between Total Hip Arthroplasty for Fracture vs Osteoarthritis

The Journal of arthroplasty, 2017-09, Vol.32 (9), p.S3-S7

2017

Volltextzugriff (PDF)

ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non–small cell lung cancer

Seminars in oncology, 2002-02, Vol.29 (1), p.37-46

2002

Volltextzugriff (PDF)

Identification of a novel CD56- lymphokine-activated killer cell precursor in cancer patients receiving recombinant interleukin 2

Cancer research (Chicago, Ill.), 1992-11, Vol.52 (22), p.6318-6322

1992

Volltextzugriff (PDF)

1 – 25 von 406

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(369)
Mit Volltextzugriff
(322)

Publikationsform

Sprache

Englisch
(394)
Deutsch
(14)
Spanisch
(2)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines

A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop

PTTG1 Levels Are Predictive of Saracatinib Sensitivity in Ovarian Cancer Cell Lines

Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas

Expression of Her-2/neu in Human Lung Cancer Cell Lines by Immunohistochemistry and Fluorescence in Situ Hybridization and its Relationship to in Vitro Cytotoxicity by Trastuzumab and Chemotherapeutic Agents

Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines

The Effects of Cetuximab Alone and in Combination With Radiation and/or Chemotherapy in Lung Cancer

Effects of recombinant neutral endopeptidase (EC 3.4.24.11) on the growth of lung cancer cell lines in vitro and in vivo

288 POSTER The selective Aurora B kinase inhibitor AZD1152 inhibits in vitro growth in small cell lung cancer (SCLC) cell lines

"Total Synthesis" Supramolecular Style: Design and Hydrogen-Bond-Directed Assembly of Ternary Supermolecules

A High-Yielding Supramolecular Reaction

436 COMBINING THE SRC INHIBITOR AZD0530 WITH IONIZING RADIATION YIELDS ADDITIVE EFFECTS WITHOUT MODULATION OF PHOSPHOSITES ON SRC, EPIDERMAL GROWTH FACTOR RECEPTOR, OR MITOGEN-ACTIVATED PROTEIN KINASE

Altered HOX and WNT7A Expression in Human Lung Cancer

Epidermal growth factor receptor family in lung cancer and premalignancy

Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines

Targeted therapies for non–small-cell lung cancer: biology, rationale, and preclinical results from a radiation oncology perspective

Peritoneal catheters and exit-site practices: toward optimum peritoneal access

Do Polymorphic Compounds Make Good Cocrystallizing Agents? A Structural Case Study that Demonstrates the Importance of Synthon Flexibility

Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma

Heteromeric intermolecular interactions as synthetic tools for the formation of binary co-crystals

Bradykinin Antagonist Dimer, CU201, Inhibits the Growth of Human Lung Cancer Cell Lines by a "Biased Agonist" Mechanism

Exisulind in Combination with Docetaxel Inhibits Growth and Metastasis of Human Lung Cancer and Prolongs Survival in Athymic Nude Rats with Orthotopic Lung Tumors

The Lawrence D. Dorr Surgical Techniques & Technologies Award: Differences in Postoperative Outcomes Between Total Hip Arthroplasty for Fracture vs Osteoarthritis

ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non–small cell lung cancer

Identification of a novel CD56- lymphokine-activated killer cell precursor in cancer patients receiving recombinant interleukin 2

Suchergebnisse filtern